RA Capital Management »

Ceribell shares owned by RA Capital Management

Quarter-by-quarter ownership of Ceribell (CBLL) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Ceribell

Tip: Access up to 7 years of quarterly data

All positions including Ceribell held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ceribell by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $16M 825k 19.21
2024-12-31 $21M 825k 25.88

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Rhythm Pharmaceuticals SH (RYTM)
Vaxcyte SH (PCVX)
Avidity Biosciences SH (RNA)
Cidara Therapeutics SH (CDTX)
Sionna Therapeutics SH (SION)
89bio SH (ETNB)
Newamsterdam Pharma Co Nv SH (NAMS)
Mineralys Therapeutics SH (MLYS)
Janux Therapeutics SH (JANX)
Arcellx SH (ACLX)
Lenz Therapeutics SH (LENZ)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
Wave Life Sciences SH (WVE)

View all positions for RA Capital Management

Top funds holding Ceribell

FMR
Tpg Gp A
Red Tree Management
BlackRock
Vanguard Group
Yu Fan
ABG-WTT Global Life Science Capital Partners GP
TimesSquare Capital Management
Federated Investors
Millennium Management
Geode Capital Management
Massachusetts Financial Services
Franklin Resources
CenterBook Partners
Redmile Group

View all funds holding Ceribell